J.-L. Lee

EV-301 long-term outcomes: 24-month findings from the phase III trial of enfortumab vedotin versus chemotherapy in patients with previously treated advanced urothelial carcinoma

Jonathan E. Rosenberg, Thomas Powles, Guru Sonpavde et al. · Annals of Oncology · 2023 · 153 citations · Full text

Medicine, Oncology, Pharmacotherapy +8

Multicenter phase II study of sunitinib in patients with non-clear cell renal cell carcinoma

J.-L. Lee, Jin‐Hee Ahn, Ho Yeong Lim et al. · Annals of Oncology · 2012 · 100 citations · Full text

Medicine, Oncology, Pharmacology +10

The Efficacy and Safety of Sunitinib in Korean Patients with Advanced Renal Cell Carcinoma: High Incidence of Toxicity Leads to Frequent Dose Reduction

Changhee Yoo, Jeong Eun Kim, J.-L. Lee et al. · Japanese Journal of Clinical Oncology · 2010 · 86 citations

Medicine, Oncology, Pharmacology +14

Docetaxel Monotherapy as a Second-line Treatment after Failure of Fluoropyrimidine and Platinum in Advanced Gastric Cancer: Experience of 154 Patients with Prognostic Factor Analysis

Jae‐Cheol Jo, J.-L. Lee, M.-H. Ryu et al. · Japanese Journal of Clinical Oncology · 2007 · 43 citations

Medicine, Oncology, Pharmacology +12

A Case of Bone Marrow Necrosis with Thrombotic Thrombocytopenic Purpura as a Manifestation of Occult Colon Cancer

J.-L. Lee · Japanese Journal of Clinical Oncology · 2004 · 37 citations · Full text

Medicine, Hematology, Pathology +12